Warburg Pincus Partners LLC

CIK 1322709 · last filed 2013-12-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.11B

Companies

16

Total Filings

33

Lifetime Open-Market Net

-$2.10B

Filer Profile

Reported Address
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Phone
(212) 878-0600
State of Incorporation
NY
Related Filers
PINCUS & CO. WARBURG — 311 joint filings, latest 2014-09-10
WARBURG PINCUS LLC — 311 joint filings, latest 2014-09-10
CHARLES R KAYE — 232 joint filings, latest 2014-09-10
Joseph P. Landy — 232 joint filings, latest 2014-09-10
Warburg Pincus X GP L.P. — 110 joint filings, latest 2014-09-10
Warburg Pincus X, L.P. — 110 joint filings, latest 2014-09-10
Warburg Pincus Private Equity IX, L.P. — 99 joint filings, latest 2014-06-06
Warburg Pincus IX LLC — 98 joint filings, latest 2014-06-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BPI Director 27,710,574 $24.37 $675.27M $0 1 2013-12-20
Vital Energy, Inc. (LPI) Delisted Director 767,800 $48.09 $36.92M -$389.52M 5 2013-09-25
PRI Director 0 $292.44 $0 -$776.52M 1 2013-06-05
BLDR 10%+ Owner 24,863,266 $60.37 $1.50B $1.52M 2 2012-06-11
FIS Director 41,127,238 $38.14 $1.57B $0 3 2011-12-20
China Biologic Products, Inc. (CBPO) Delisted Director 5,422,057 $119.99 $650.59M $30.19M 1 2011-05-31
Polypore International, Inc. (PPO) Delisted Director 11,985,775 -$1.01B 4 2011-05-25
ev3 Inc. (EVVV) Delisted 10%+ Owner 0 $0 2 2010-07-13
Nuance Communications, Inc. (NUAN) Delisted Director 61,870,814 $55.99 $3.46B $0 2 2010-04-07
BILL BARRETT CORP (BBG) Delisted 10%+ Owner 3,128,214 $3.35M 3 2010-03-01
Altus Pharmaceuticals Inc. (ALTU) Delisted 10%+ Owner 1,784,948 $10.12 $18.06M -$652.2K 1 2009-04-20
TDG 10%+ Owner 7,332,018 $1140.32 $8.36B $0 1 2009-03-24
NYFIX INC (NYFX) Delisted 10%+ Owner 6,645,054 $43.11M 4 2009-01-05
Metavante Technologies, Inc. (MV) Delisted 10%+ Owner 29,772,613 $0 1 2008-06-13
NEUROGEN CORP (NRGN) Delisted 10%+ Owner 8,571,429 $0 1 2008-04-14
NESS TECHNOLOGIES INC (NSTC) Delisted 3,352,667 $10.47 $35.12M $0 1 2007-03-20

Recent Filings · Page 2 of 4

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-05-31 China Biologic Products, Inc. (CBPO) Delisted Buy (P) +1,864,449 $30.19M EDGAR
2011-05-25 Polypore International, Inc. (PPO) Delisted Other (J) −9,051,072 $0 EDGAR
2011-03-24 Polypore International, Inc. (PPO) Delisted Sell (S) −12,638,790 -$658.10M EDGAR
2011-03-22 FIS Grant (A) +259,245 $2.6K EDGAR
2011-03-01 Polypore International, Inc. (PPO) Delisted Other (J) −12,506,130 $0 EDGAR
2010-12-15 Polypore International, Inc. (PPO) Delisted Sell (S) −9,093,888 -$350.21M EDGAR
2010-07-13 ev3 Inc. (EVVV) Delisted U −108,606,280 -$2.44B EDGAR
2010-04-07 Nuance Communications, Inc. (NUAN) Delisted Exer (M) +25,000,000 $123.50M EDGAR
2010-03-23 FIS Grant (A) +4,482,486 $44.8K EDGAR
2010-03-01 BILL BARRETT CORP (BBG) Delisted Other (J) −21,375,018 $0 EDGAR
Showing 1120 of 33
Page 2 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.